prostate-report.org

Low dose, alternating electric current inhibits growth of prostate cancer

Among a number of minimally invasive technologies that exist for the treatment of prostate cancer, each with their associated morbidities, urologists think low dose alternating electric current (LDAEC) may inhibit prostate cancer growth.

A research group at the University of Washington in Seattle is investigating the efectiveness of low-dose, alternating electric current as a possible treatment for early stage prostate cancer in order to determine its effects on normal tissue using a mouse model.

According to the authors, the most effective tumor volume reduction was seen in tumors treated with 25 mA for 15 min, and a longer treatment time did not lead to a better treatment effect. The authors intend to continue this research.